The US Food and Drug Administration (FDA) has approved the Sentosa SQ HIV genotyping assay (Vela Diagnostics USA Inc) that uses next generation sequencing technology to detect HIV-1 drug resistance mutations from a blood sample. Recent data suggest that the percentage of people living with HIV around the world that have resistance to some HIV drugs has…



